Dataset Information

Effects of Fungicides on Rat's Neurosteroid Synthetic Enzymes.

ABSTRACT: Exposure to environmental endocrine disruptors may interfere with nervous system's activity. Fungicides such as tebuconazole, triadimefon, and vinclozolin have antifungal activities and are used to prevent fungal infections in agricultural plants. In the present study, we studied effects of tebuconazole, triadimefon, and vinclozolin on rat's neurosteroidogenic 5?-reductase 1 (5?-Red1), 3?-hydroxysteroid dehydrogenase (3?-HSD), and retinol dehydrogenase 2 (RDH2). Rat's 5?-Red1, 3?-HSD, and RDH2 were cloned and expressed in COS-1 cells, and effects of these fungicides on them were measured. Tebuconazole and triadimefon competitively inhibited 5?-Red1, with IC50 values of 8.670 ± 0.771 × 10-6?M and 17.390 ± 0.079 × 10-6?M, respectively, while vinclozolin did not inhibit the enzyme at 100 × 10-6?M. Triadimefon competitively inhibited 3?-HSD, with IC50 value of 26.493 ± 0.076 × 10-6?M. Tebuconazole and vinclozolin weakly inhibited 3?-HSD, with IC50 values about 100 × 10-6?M, while vinclozolin did not inhibit the enzyme even at 100 × 10-6?M. Tebuconazole and triadimefon weakly inhibited RDH2 with IC50 values over 100 × 10-6?M and vinclozolin did not inhibit this enzyme at 100 × 10-6?M. Docking study showed that tebuconazole, triadimefon, and vinclozolin bound to the steroid-binding pocket of 3?-HSD. In conclusion, triadimefon potently inhibited rat's neurosteroidogenic enzymes, 5?-Red1 and 3?-HSD.

SUBMITTER: Shen X

PROVIDER: S-EPMC5546122 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Effects of Fungicides on Rat's Neurosteroid Synthetic Enzymes.

Shen Xiuwei X Chen Fan F Chen Lanlan L Su Ying Y Huang Ping P Ge Ren-Shan RS

BioMed research international 20170724

Exposure to environmental endocrine disruptors may interfere with nervous system's activity. Fungicides such as tebuconazole, triadimefon, and vinclozolin have antifungal activities and are used to prevent fungal infections in agricultural plants. In the present study, we studied effects of tebuconazole, triadimefon, and vinclozolin on rat's neurosteroidogenic 5α-reductase 1 (5α-Red1), 3α-hydroxysteroid dehydrogenase (3α-HSD), and retinol dehydrogenase 2 (RDH2). Rat's ...[more]

PMID: 28812018

Similar Datasets

Project description:With each passing year, the number of people suffering from mental disorders grows at a disturbing speed. Neuroactive steroids are a new promising group of drugs with the potential for use in many diseases like postpartum depression, postnatal psychosis, major depression, insomnia, bipolar disorder, and Parkinson's tremor, due to their ability to modulate the activity of GABAA receptor. Neurosteroids are progesterone metabolites that are synthesized from cholesterol or steroid hormones in various brain regions. They regulate neuronal development, regeneration, and neurotransmission. They are implicated in mood disorders, anxiety disorders, schizophrenia, PTSD, and impulsive aggression. Neurosteroids have been studied for their potential to prevent or treat neurodegenerative diseases such as Alzheimer's disease and HIV-associated dementia. They can promote neurogenesis, neuronal survival, myelination, and memory function. They can also affect the growth and sensitivity of hormone-dependent brain tumors such as gliomas. Zuranolone, a newly registered neurosteroid drug has shown huge flexibility in both clinical and ambulatory treatment thanks to its pharmacokinetic traits, especially the possibility for oral administration, unlike its predecessor Brexanolone. Zuranolone is a synthetic positive allosteric modulator of the GABAA receptor that can be taken orally. The review aims to summarize the current knowledge on zuranolone as a novel neurosteroid drug for various mental disorders, especially for postpartum mental disorders for which this drug was meant originally. It covers studies indexed in the PubMed, Scopus, and Web of Science databases published since 2017. Keywords used in the search, as well as inclusion and exclusion criteria, are given in the aims and methodology section. The review explains the evidence for the role of neurosteroids, especially allopregnanolone, in the pathophysiology and treatment of postpartum depression. It discusses the mechanisms of neurosteroid action, the changes in neurosteroid levels during pregnancy and postpartum, and the clinical trials of brexanolone and zuranolone, two synthetic analogs of allopregnanolone, for postpartum depression. It provides an overview of the biosynthesis and metabolism of neurosteroids in the central and peripheral nervous system. Furthermore, it explains the different sources and pathways of neurosteroid production and the factors that influence their synthesis and regulation, such as stress, hormones, drugs, and genetic variations. The review also explores the potential relevance of neurosteroids for other psychiatric disorders, such as major depression, bipolar disorder, post-traumatic stress disorder (PTSD), schizophrenia, and premenstrual dysphoric disorder. Finally, it highlights the associations between neurosteroid levels and symptom severity and the effects of neurosteroid modulation on mood, cognition, and neuroplasticity.

Project description:BackgroundMost currently available active antidepressant drugs are selective serotonin/noradrenaline reuptake inhibitors. However, as their clinical efficacy is not immediate, long-term administration is often accompanied by substantial side effects, and numerous patients remain non- or partial responders. We have recently found that the synthetic neurosteroid derivative 3?-methoxypregnenolone, which binds to the microtubule-associated protein-2, can provide a novel therapeutic approach in experimental model of depressive disorders in rats. To further validate the antidepressant-like efficacy of 3?-methoxypregnenolone, we investigated effects of a longer treatment (4-week oral administration; 50mg/kg/d) in a nonrodent species, the tree shrew, exposed to psychosocial stress that elicits close-to-human alterations observed in patients with depressive disorders.MethodsDuring the experimental period, physiological parameters were registered, including core body temperature and electroencephalogram, while animals were videotaped to analyze their avoidance behavior. Morning urine samples were collected for measurements of cortisol and noradrenaline levels.ResultsWe found that treatment with 3?-methoxypregnenolone abolished stress-triggered avoidance behavior and prevented hormone hypersecretion, hypothermia, and sleep disturbances, further suggesting its antidepressant-like efficacy. Comparative treatment with fluoxetine also prevented some of the physiological alterations, while the hypersecretion of cortisol and sleep disturbances were not or partially restored by fluoxetine, suggesting a better efficacy of 3?-methoxypregnenolone. Alpha-tubulin isoforms were measured in hippocampi: we found that 3?-methoxypregnenolone reversed the specific decrease in acetylation of ?-tubulin induced by psychosocial stress, while it did not modify the psychosocial stress-elicited reduction of tyrosinated ?-tubulin.ConclusionsTaken together, these data strongly suggest a potent antidepressant-like effect of 3?-methoxypregnenolone on translational parameters.

Dataset Information

Effects of Fungicides on Rat's Neurosteroid Synthetic Enzymes.

Publications

Effects of Fungicides on Rat's Neurosteroid Synthetic Enzymes.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets